Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company operates in three segments, including Cardiovascular, Rhythm Management and MedSurg. The Company’s cardiovascular segment includes Interventional Cardiology and Peripheral Interventions. The Company’s Rhythm Management segment includes Cardiac Rhythm Management and Electrophysiology. The Company’s Medsurg segment includes Endoscopy, Urology and Women’s Health, and Neuromodulation. The Company’s Interventional Cardiology business markets products, which are used for the treatment of atherosclerosis, a cause of coronary artery obstructive disease. Peripheral Interventions business sells products designed to treat peripheral disease, including medical devices used in percutaneous transluminal angioplasty (PTA) and peripheral vascular stenting.